Literature DB >> 24665867

Variability in clinical features of early versus late cardiovascular implantable electronic device pocket infections.

Mariko Welch1, Daniel Z Uslan, Arnold J Greenspon, Muhammad R Sohail, Larry M Baddour, Elisabeth Blank, Roger G Carrillo, Stephan B Danik, Ana Del Rio, Walter Hellinger, Katherine Y Le, Jose M Miro, Christoph Naber, James E Peacock, Holenarasipur R Vikram, Chi-Hong Tseng, Jordan M Prutkin.   

Abstract

BACKGROUND: Cardiovascular implantable electronic device (CIED) pocket infections are often related to recent CIED placement or manipulation, but these infections are not well characterized. The clinical presentation of CIED pocket infection, based on temporal onset related to last CIED procedure, deserves further study.
METHODS: The MEDIC (Multicenter Electrophysiologic Device Infection Cohort) prospectively enrolled subjects with CIED infection. Subjects were stratified into those whose infection occurred <12 months (early) or ≥ 12 months (late) since their last CIED-related procedure.
RESULTS: There were 132 subjects in the early group and 106 in the late group. There were more females (P = 0.009) and anticoagulation use (P = 0.039) in the early group. Subjects with early infections were more likely to have had a generator change or lead addition as their last procedure (P = 0.03) and had more prior CIED procedures (P = 0.023). Early infections were more likely to present with pocket erythema (P < 0.001), swelling (P < 0.001), and pain (P = 0.007). Late infections were more likely to have pocket erosion (P = 0.005) and valvular vegetations (P = 0.009). In bacteremic subjects, early infections were more likely healthcare-associated (P < 0.001). In-hospital and 6-month mortality were equivalent.
CONCLUSION: A total of 45% of patients with CIED pocket infection presented >12 months following their last CIED-related procedure. Patients with early infection were more likely to be female, on anticoagulation, and present with localized inflammation, whereas those with late infection were more likely to have CIED erosion or valvular endocarditis. ©2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  cardiac implantable devices; device infection; endocarditis

Mesh:

Year:  2014        PMID: 24665867     DOI: 10.1111/pace.12385

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  6 in total

Review 1.  Prevention, Diagnosis, and Treatment of Cardiac Implantable Electronic Device Infections.

Authors:  Steven Leung; Stephan Danik
Journal:  Curr Cardiol Rep       Date:  2016-06       Impact factor: 2.931

2.  Management of Cardiovascular Implantable Electronic Devices Infections in High-Risk Patients.

Authors:  Charles Kennergren
Journal:  Arrhythm Electrophysiol Rev       Date:  2015-04-10

3.  Predictors of Bloodstream Infection in Patients Presenting With Cardiovascular Implantable Electronic Device Pocket Infection.

Authors:  Zerelda Esquer Garrigos; Merit P George; Sarwat Khalil; Prakhar Vijayvargiya; Omar M Abu Saleh; Paul A Friedman; James M Steckelberg; Daniel C DeSimone; Walter R Wilson; Larry M Baddour; M Rizwan Sohail
Journal:  Open Forum Infect Dis       Date:  2019-02-21       Impact factor: 3.835

4.  Antibiotic Prophylaxis and Treatment in Early Cardiac Implantable Electronic Devices Infection.

Authors:  Osama Alshoubaki; Ziad Al Darabaa; Omar Odat; Ashraf Qubbaj; Ramzi Alhyari; Sakher Alshare; Issa Ghanma
Journal:  Med Arch       Date:  2021-02

5.  Early, Delayed and Late Cardiac Implantable Electronic Device Infections: Do the Timing of Onset and Pathogens Matter?

Authors:  Anna Polewczyk; Wojciech Jacheć; Maciej Polewczyk; Dorota Szczęśniak-Stańczyk; Andrzej Kutarski
Journal:  J Clin Med       Date:  2022-07-06       Impact factor: 4.964

Review 6.  Cardiac Implantable Electronic Devices Infection Assessment, Diagnosis and Management: A Review of the Literature.

Authors:  Filippo Toriello; Massimo Saviano; Andrea Faggiano; Domitilla Gentile; Giovanni Provenzale; Alberto Vincenzo Pollina; Elisa Gherbesi; Lucia Barbieri; Stefano Carugo
Journal:  J Clin Med       Date:  2022-10-06       Impact factor: 4.964

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.